You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Castration-Resistant Prostatic Neoplasms

Showing 26 - 50 of 7,136
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Castration-resistant Prostate Cancer Trial in Salt Lake City (Enfortumab vedotin)

Recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • Enfortumab vedotin
  • Salt Lake City, Utah
    Huntsman Cancer Institute
Jan 24, 2023

Metastatic Castration-resistant Prostate Cancer Trial (Darolutamide, Docetaxel or cabazitaxel)

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • (no location specified)
Feb 28, 2023

Glioma, Glioma, Malignant, Glioma, Mixed Trial in United States (NUV-422)

Terminated
  • Glioma
  • +23 more
  • Tucson, Arizona
  • +11 more
Sep 30, 2022

Prostatic Tumors, Exercise, Castration-resistant Prostate Cancer Trial in Ghent (Exercise)

Completed
  • Prostatic Neoplasms
  • +3 more
  • Exercise
  • Ghent, Oost-Vlaanderen, Belgium
    University Hospital ghent
Dec 22, 2022

Darolutamide, Enzalutamide and Apalutamide and How Well These

Not yet recruiting
  • Non-metastatic Castration-resistant Prostate Cancer
  • Whippany, New Jersey
    Bayer
Aug 25, 2023

Advanced Solid Tumor, Ovarian Cancer, Ovary Cancer Trial in United States (NUV-868, Olaparib, Enzalutamide)

Recruiting
  • Advanced Solid Tumor
  • +26 more
  • Baltimore, Maryland
  • +3 more
Aug 1, 2022

PRostate Olaparib Real World Evidence Study

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer
    • (no location specified)
    Sep 4, 2023

    Metastatic Castration-Resistant Prostate Cancer (mCRPC) Trial in Oklahoma City (Sipuleucel-T)

    Not yet recruiting
    • Metastatic Castration-Resistant Prostate Cancer (mCRPC)
    • Sipuleucel-T
    • Oklahoma City, Oklahoma
      Stephenson's Cancer Center
    Mar 28, 2023

    Prostatic Tumors Trial in Beijing, NanJing, ShangHai (Apalutamide)

    Active, not recruiting
    • Prostatic Neoplasms
    • Beijing, China
    • +3 more
    Jan 17, 2023

    Metastatic Castration-resistant Prostate Cancer Trial in United States (BMS-986460)

    Recruiting
    • Metastatic Castration-resistant Prostate Cancer
    • Palo Alto, California
    • +7 more
    Oct 10, 2023

    Castrate Resistant Prostate Cancer, Metastatic Castration-resistant Prostate Cancer, Prostate Cancer Trial in San Francisco

    Not yet recruiting
    • Castrate Resistant Prostate Cancer
    • +3 more
    • San Francisco, California
      University of California, San Francisco
    Mar 1, 2023

    Metastatic Castration-resistant Prostate Cancer, mCRPC Trial in Seoul ([177Lu]Ludotadipep)

    Recruiting
    • Metastatic Castration-resistant Prostate Cancer, mCRPC
    • Seoul, Korea, Republic of
      The Catholic University of Korea, Seoul, St, Mary's Hospital, 22
    Dec 8, 2022

    Prostatic Tumors, Metastatic Castration-Resistant Prostate Cancer Trial in Worldwide (Abiraterone Acetate, Prednisone,

    Active, not recruiting
    • Prostatic Neoplasms
    • Metastatic Castration-Resistant Prostate Cancer
    • Abiraterone Acetate
    • +2 more
    • Los Angeles, California
    • +6 more
    Jan 18, 2023

    Castration-resistant Prostate Cancer, Metastatic Cancer Trial (Cabozantinib, Nivolumab)

    Not yet recruiting
    • Castration-resistant Prostate Cancer
    • Metastatic Cancer
    • (no location specified)
    Aug 12, 2022

    Prostate Cancer Trial in Tampa (Abiraterone Acetate)

    Active, not recruiting
    • Prostate Cancer
    • Abiraterone Acetate
    • Tampa, Florida
      H. Lee Moffitt Cancer Center and Research Institute
    Jan 3, 2023

    Patients With Metastatic Castration-resistant Prostate Cancer Trial (177Lu-PSMA-617 PET scan)

    Not yet recruiting
    • Patients With Metastatic Castration-resistant Prostate Cancer
    • 177Lu-PSMA-617 PET scan
    • (no location specified)
    Nov 13, 2023

    Metastatic Castration-Resistant Prostate Cancer (mCRPC) Trial (AAA617, 68Ga-PSMA-11)

    Not yet recruiting
    • Metastatic Castration-Resistant Prostate Cancer (mCRPC)
    • (no location specified)
    Aug 16, 2023

    Metastatic Castration-resistant Prostate Cancer (mCRPC) Trial (177Lu-PSMA-617, PSMA-11)

    No longer available
    • Metastatic Castration-resistant Prostate Cancer (mCRPC)
    • (no location specified)
    Jan 12, 2023

    Castration Resistant Prostate Cancer, Castration Sensitive Prostate Cancer Trial in Portland (drug, procedure, other)

    Not yet recruiting
    • Castration Resistant Prostate Cancer
    • Castration Sensitive Prostate Cancer
    • Portland, Oregon
      OHSU Knight Cancer Institute
    Jun 16, 2023

    Metastatic Castration Resistant Prostate Cancer Trial in China (AC176)

    Not yet recruiting
    • Metastatic Castration Resistant Prostate Cancer
    • Beijing, China
    • +4 more
    Jan 4, 2023

    Metastatic Castration-Resistant Prostate Cancer (mCRPC) Trial (Sipuleucel-T Injection)

    Not yet recruiting
    • Metastatic Castration-Resistant Prostate Cancer (mCRPC)
    • Sipuleucel-T Injection
    • (no location specified)
    Nov 10, 2023

    Prostatic Tumors, Castration-Resistant, Tumors by Histologic Type, Tumors, Prostate Trial in United States (P-PSMA-101 CAR-T

    Active, not recruiting
    • Prostatic Neoplasms, Castration-Resistant
    • +16 more
    • Duarte, California
    • +9 more
    Nov 15, 2022

    Metastatic Castration-resistant Prostate Cancer, mCRPC, Prostate Cancer Trial in Melbourne (Lutetium-177 PSMA-I&T, Radium-223)

    Recruiting
    • Metastatic Castration-resistant Prostate Cancer
    • +2 more
    • Melbourne, Victoria, Australia
      Peter MacCallum Cancer Centre
    Sep 26, 2022

    Prostate Cancer, Prostate Cancer Metastatic Trial in La Jolla (Abivertinib, Abiraterone)

    Recruiting
    • Prostate Cancer
    • Prostate Cancer Metastatic
    • La Jolla, California
    • +1 more
    Feb 2, 2023

    Castration-resistant Prostate Cancer Trial in Los Angeles (Apalutamide, Carotuximab)

    Not yet recruiting
    • Castration-resistant Prostate Cancer
    • Los Angeles, California
      Cedars-Sinai Medical Center
    Sep 6, 2022